2 Min Read
* Q3 non-GAAP EPS $0.32 vs est $0.28
* Q3 rev $91 mln, up 40 pct
* Reaffirms 2010 outlook
Oct 28 (Reuters) - Cardiac-device maker Thoratec Corp THOR.O posted better-than-expected quarterly results, helped by increased sales of its heart pump, HeartMate II, and kept its outlook for the full year.
For the third quarter, net income was $15.5 million, or 26 cents a share, compared with $11.8 million, or 20 cents a share, a year ago.
Excluding items, the company earned 32 cents a share.
Analysts on average were expecting 28 cents a share, according to Thomson Reuters I/B/E/S.
Product sales rose 40 percent to $91 million, above analysts' view of $89.5 million.
For 2010, the company continues to expect earnings of $1.19 to $1.23 a share, excluding items, on revenue of $380-$385 million.
Analysts on average expect the company to earn $1.23 per share on revenue of $385.5 million.
Shares of the Pleasanton, California-based company closed at $35.09 Thursday on Nasdaq. They have fallen about 18 percent since Thoratec reported second-quarter results in July. (Reporting by Suzannah Benjamin in Bangalore; Editing by Don Sebastian)